Not checked for notices yet.
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
Antonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener and 3 more
Cardiovascular Diabetology · 2020
doi:10.1186/s12933-020-01147-9
Cited by papers we hold 2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.